Balance Sheet Tokyo Electron Limited

Equities

8035

JP3571400005

Semiconductor Equipment & Testing

Market Closed - Japan Exchange Other stock markets 06:30:00 13/03/2026 GMT			5-day change	1st Jan Change
38,340.00 ^JPY	-3.55%		-8.26%	+11.71%

03-12	Japan's Nikkei ends lower on higher oil, fears of prolonged Middle East war	RE
03-12	Japan's Nikkei falls on higher oil, fears of prolonged Middle East war	RE

5cea5df5e6f1ab2bf.8MeVVjDWynXEtj6Uzo5xc2vvudSNButOWAxi4v_L4YE.p4XhHGaDhAyTg23D9r45NEbWzuP1ZaEhaEghgLO9k-aEk9QZVKCVM6bucw

Published financial data: TOKYO ELECTRON LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1,399B	2,004B	2,209B	1,831B	2,432B
Total Revenues	1,399B	2,004B	2,209B	1,831B	2,432B
Cost of Goods Sold, Total	834B	1,092B	1,225B	1,000B	1,285B
Gross Profit	565B	912B	984B	830B	1,146B
Selling General & Admin Expenses, Total	108B	154B	175B	171B	199B
R&D Expenses	137B	158B	191B	203B	250B
Other Operating Expenses, Total	244B	313B	367B	374B	449B
Operating Income	321B	599B	618B	456B	697B
Interest And Investment Income	778M	1.58B	2.44B	2.57B	3.58B
Net Interest Expenses	778M	1.58B	2.44B	2.57B	3.58B
Income (Loss) On Equity Invest.	1.11B	1.72B	2.97B	3.39B	3B
Currency Exchange Gains (Loss)	-3.15B	-2.45B	-1.4B	-4.15B	-929M
Other Non Operating Income (Expenses)	2.68B	1.6B	3.46B	5.11B	4.76B
EBT, Excl. Unusual Items	322B	602B	625B	463B	708B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-1.33B	71M	109M	10.03B	-1.17B
Asset Writedown	-	-	-438M	-	-447M
Other Unusual Items	-3.74B	-5.1B	-	221M	-1M
EBT, Incl. Unusual Items	317B	597B	625B	473B	706B
Income Tax Expense	74.1B	160B	153B	109B	162B
Earnings From Continuing Operations	243B	437B	472B	364B	544B
Net Income to Company	243B	437B	472B	364B	544B
Minority Interest	-	-	-	-	-
Net Income - (IS)	243B	437B	472B	364B	544B
Net Income to Common Incl Extra Items	243B	437B	472B	364B	544B
Net Income to Common Excl. Extra Items	243B	437B	472B	364B	544B
Per Share Items
Net EPS - Basic	520.74	935.95	1.01K	783.75	1.18K
Basic EPS - Continuing Operations	520.74	935.95	1.01K	783.75	1.18K
Basic Weighted Average Shares Outstanding	467M	467M	468M	464M	460M
Net EPS - Diluted	517.76	931.3	1K	781.2	1.18K
Diluted EPS - Continuing Operations	517.76	931.3	1K	781.2	1.18K
Diluted Weighted Average Shares Outstanding	469M	469M	470M	466M	461M
Normalized Basic EPS	431.51	805.33	835.05	623.38	961.18
Normalized Diluted EPS	429.05	801.33	831.77	621.35	958.48
Dividend Per Share	260.33	467.67	503.67	393	592
Payout Ratio	45.09	38.04	53.65	55.63	43.42
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	355B	636B	661B	509B	760B
EBITA	321B	599B	618B	456B	697B
EBIT	321B	599B	618B	456B	697B
Effective Tax Rate - (Ratio)	23.37	26.75	24.53	23.12	22.94
Normalized Net Income	201B	376B	391B	289B	442B
Non-Cash Pension Expense	1.02B	887M	-1.09B	-2.58B	-5.17B
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	137B	158B	191B	203B	250B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	187B	274B	473B	462B	416B
Short Term Investments	125B	97B	-	10.16B	80B
Total Cash And Short Term Investments	312B	371B	473B	473B	496B
Accounts Receivable, Total	192B	434B	465B	391B	485B
Other Receivables	82.7B	110B	124B	-	-
Total Receivables	274B	544B	589B	391B	485B
Inventory	415B	474B	652B	763B	749B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	14.5B	19.3B	26.97B	73.88B	69.93B
Total Current Assets	1,016B	1,409B	1,741B	1,700B	1,801B
Net Property Plant And Equipment	197B	223B	259B	337B	442B
Long-term Investments	142B	194B	224B	344B	278B
Other Intangibles, Total	17.16B	22.54B	28.56B	32.38B	35.85B
Deferred Tax Assets Long-Term	53.13B	45.65B	58.6B	42.1B	69.56B
Other Long-Term Assets, Total	2M	1M	2M	2M	1M
Total Assets	1,425B	1,894B	2,312B	2,456B	2,626B
Liabilities
Accounts Payable, Total	90.61B	121B	116B	92.36B	108B
Accrued Expenses, Total	34.25B	44.87B	43.34B	43.73B	55.22B
Current Income Taxes Payable	49.27B	107B	71.18B	80.01B	109B
Other Current Liabilities	154B	196B	399B	396B	405B
Total Current Liabilities	328B	469B	630B	612B	678B
Pension & Other Post Retirement Benefits	62.14B	62.53B	60.37B	56.14B	56.47B
Other Non Current Liabilities	11B	16.3B	21.81B	28.24B	36.38B
Total Liabilities	401B	547B	712B	696B	771B
Common Stock, Total	54.96B	54.96B	54.96B	54.96B	54.96B
Additional Paid In Capital	78.01B	78.01B	78.01B	78.01B	78.01B
Retained Earnings	835B	1,105B	1,322B	1,480B	1,784B
Treasury Stock	-30.74B	-27.42B	-22.03B	-135B	-278B
Comprehensive Income and Other	87.09B	137B	166B	282B	216B
Total Common Equity	1,025B	1,347B	1,600B	1,760B	1,855B
Minority Interest	-	-	-	-	-
Total Equity	1,025B	1,347B	1,600B	1,760B	1,855B
Total Liabilities And Equity	1,425B	1,894B	2,312B	2,456B	2,626B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	467M	467M	468M	463M	458M
ECS Total Common Shares Outstanding	467M	467M	465M	463M	458M
Book Value / Share	2.2K	2.88K	3.44K	3.8K	4.05K
Tangible Book Value	1,007B	1,325B	1,571B	1,728B	1,819B
Tangible Book Value Per Share	2.16K	2.83K	3.38K	3.73K	3.97K
Total Debt	0	0	0	0	0
Net Debt	-312B	-371B	-473B	-473B	-496B
Debt Equivalent of Unfunded Proj. Benefit Obligation	50.12B	46.35B	40.99B	26.71B	24.9B
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Inventories - Raw Materials, Total	64.83B	146B	253B	305B	268B
Inventories - Work In Process, Total	80.74B	144B	162B	174B	190B
Inventories - Finished Goods, Total	270B	184B	237B	284B	292B
Full Time Employees	14.48K	15.63K	17.2K	17.7K	19.57K
Accumulated Allowance for Doubtful Accounts (Supple)	99M	160M	184M	353M	160M
Order Backlog	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	317B	597B	625B	473B	706B
Depreciation & Amortization - CF	33.84B	36.73B	42.93B	52.34B	62.15B
Amortization of Goodwill and Intangible Assets - (CF)	199M	206M	168M	73M	117M
Depreciation & Amortization, Total	34.04B	36.93B	43.1B	52.41B	62.26B
(Gain) Loss From Sale Of Asset	-	-	-	-10.03B	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	-86.1B	-104B	-206B	-118B	-142B
Change In Accounts Receivable	-37.74B	-196B	-24.75B	84.85B	-97.52B
Change In Inventories	-17.23B	-100B	-173B	-97.71B	8.48B
Change In Accounts Payable	-13.95B	18.89B	-11.41B	-29.63B	46.61B
Change in Other Net Operating Assets	-50.17B	30.58B	174B	79.52B	-1.86B
Cash from Operations	146B	283B	426B	435B	582B
Capital Expenditure	-53.81B	-56.15B	-66.9B	-117B	-158B
Sale of Property, Plant, and Equipment	-	-	-	12.97B	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-7.12B	-8.95B	-9.42B	-7.99B	-9.66B
Investment in Marketable and Equity Securities, Total	44.94B	9.98B	35.02B	-10.09B	156M
Other Investing Activities, Total	-2.28B	-506M	-461M	-3.05B	-1.73B
Cash from Investing	-18.27B	-55.63B	-41.76B	-125B	-170B
Repurchase of Common Stock	-4.34B	-15M	-1.73B	-120B	-150B
Common Dividends Paid	-110B	-166B	-253B	-202B	-236B
Common & Preferred Stock Dividends Paid	-110B	-166B	-253B	-202B	-236B
Other Financing Activities, Total	-644M	-989M	-1.82B	-2.53B	-2.55B
Cash from Financing	-115B	-167B	-257B	-325B	-389B
Foreign Exchange Rate Adjustments	4.95B	9.16B	8.84B	4.58B	-264M
Miscellaneous Cash Flow Adjustments	-2M	-	-	1M	-2M
Net Change in Cash	18.03B	69.66B	137B	-10.86B	23.46B
Supplemental Items
Cash Income Tax Paid (Refund)	87.77B	106B	209B	119B	143B
Levered Free Cash Flow	38.56B	154B	284B	235B	319B
Unlevered Free Cash Flow	38.56B	154B	284B	235B	319B
Change In Net Working Capital	135B	192B	69.12B	-21.96B	10.59B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	14.83	22.56	18.36	11.96	17.15
Return on Total Capital	21.62	31.59	26.21	16.98	24.11
Return On Equity %	26.2	36.86	32.01	21.67	30.1
Return on Common Equity	26.2	36.86	32.01	21.67	30.1
Margin Analysis
Gross Profit Margin %	40.38	45.5	44.56	45.36	47.14
SG&A Margin	7.69	7.7	7.94	9.35	8.18
EBITDA Margin %	25.35	31.75	29.91	27.79	31.24
EBITA Margin %	22.94	29.92	27.97	24.93	28.68
EBIT Margin %	22.92	29.91	27.96	24.93	28.68
Income From Continuing Operations Margin %	17.36	21.81	21.35	19.88	22.38
Net Income Margin %	17.36	21.81	21.35	19.88	22.38
Net Avail. For Common Margin %	17.36	21.81	21.35	19.88	22.38
Normalized Net Income Margin	14.39	18.77	17.69	15.81	18.19
Levered Free Cash Flow Margin	2.76	7.69	12.84	12.81	13.14
Unlevered Free Cash Flow Margin	2.76	7.69	12.84	12.81	13.14
Asset Turnover
Asset Turnover	1.03	1.21	1.05	0.77	0.96
Fixed Assets Turnover	7.51	9.54	9.16	6.14	6.24
Receivables Turnover (Average Receivables)	8.19	6.41	4.92	4.28	5.55
Inventory Turnover (Average Inventory)	2.07	2.46	2.18	1.41	1.7
Short Term Liquidity
Current Ratio	3.1	3.01	2.76	2.78	2.66
Quick Ratio	1.79	1.95	1.69	1.41	1.45
Operating Cash Flow to Current Liabilities	0.45	0.6	0.68	0.71	0.86
Days Sales Outstanding (Average Receivables)	44.56	56.96	74.23	85.55	65.79
Days Outstanding Inventory (Average Inventory)	176.65	148.61	167.81	258.91	214.7
Average Days Payable Outstanding	39.7	33.55	30.86	34.37	28.76
Cash Conversion Cycle (Average Days)	181.5	172.01	211.18	310.09	251.73
Long Term Solvency
Total Liabilities / Total Assets	28.12	28.9	30.8	28.34	29.35
Net Debt / EBITDA	-0.88	-0.58	-0.72	-0.93	-0.65
Net Debt / (EBITDA - Capex)	-1.04	-0.64	-0.8	-1.21	-0.83
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	24.11	43.22	10.24	-17.13	32.83
Gross Profit, 1 Yr. Growth %	25	61.4	7.96	-15.66	38.06
EBITDA, 1 Yr. Growth %	33.06	79.35	3.87	-23.02	49.33
EBITA, 1 Yr. Growth %	35.12	86.82	3.07	-26.15	52.83
EBIT, 1 Yr. Growth %	35.14	86.87	3.08	-26.14	52.83
Earnings From Cont. Operations, 1 Yr. Growth %	31.17	79.91	7.9	-22.82	49.5
Net Income, 1 Yr. Growth %	31.17	79.91	7.9	-22.82	49.5
Normalized Net Income, 1 Yr. Growth %	31.48	86.81	3.9	-25.91	52.8
Diluted EPS Before Extra, 1 Yr. Growth %	33.44	79.87	7.79	-22.18	50.93
Accounts Receivable, 1 Yr. Growth %	27.71	126.4	7.13	-15.85	24.14
Inventory, 1 Yr. Growth %	5.94	14.09	37.64	16.98	-1.81
Net Property, Plant and Equip., 1 Yr. Growth %	12.18	13.26	16.14	30.21	30.93
Total Assets, 1 Yr. Growth %	11.49	32.91	22.02	6.27	6.9
Tangible Book Value, 1 Yr. Growth %	23.04	31.48	18.61	9.98	5.3
Common Equity, 1 Yr. Growth %	23.49	31.48	18.74	10.04	5.4
Cash From Operations, 1 Yr. Growth %	-42.36	94.25	50.42	1.98	33.92
Capital Expenditures, 1 Yr. Growth %	8.99	4.36	19.13	74.89	35.37
Levered Free Cash Flow, 1 Yr. Growth %	-77.15	299.42	84.24	-17.33	36.2
Unlevered Free Cash Flow, 1 Yr. Growth %	-77.15	299.42	84.24	-17.33	36.2
Dividend Per Share, 1 Yr. Growth %	32.82	79.64	7.7	-21.97	50.64
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.62	33.32	25.65	-4.42	4.92
Gross Profit, 2 Yr. CAGR %	3.62	42.04	32	-4.58	7.91
EBITDA, 2 Yr. CAGR %	2.86	54.48	36.49	-10.58	7.21
EBITA, 2 Yr. CAGR %	1.59	58.88	38.77	-12.75	6.24
EBIT, 2 Yr. CAGR %	1.62	58.92	38.79	-12.74	6.25
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.07	53.62	39.32	-8.75	7.42
Net Income, 2 Yr. CAGR %	-1.07	53.62	39.32	-8.75	7.42
Normalized Net Income, 2 Yr. CAGR %	0.07	56.72	39.32	-12.26	6.4
Diluted EPS Before Extra, 2 Yr. CAGR %	1.52	54.93	39.24	-8.41	8.38
Accounts Receivable, 2 Yr. CAGR %	14.21	70.04	55.74	-5.05	2.21
Inventory, 2 Yr. CAGR %	8.28	9.94	25.31	26.89	7.17
Net Property, Plant and Equip., 2 Yr. CAGR %	14.56	12.72	14.69	22.98	30.57
Total Assets, 2 Yr. CAGR %	6.46	21.73	27.35	13.87	6.58
Tangible Book Value, 2 Yr. CAGR %	7.05	27.19	24.88	14.21	7.62
Common Equity, 2 Yr. CAGR %	7.41	27.42	24.95	14.31	7.7
Cash From Operations, 2 Yr. CAGR %	-12.28	5.81	70.94	23.86	16.86
Capital Expenditures, 2 Yr. CAGR %	7.55	6.65	11.5	44.34	53.86
Levered Free Cash Flow, 2 Yr. CAGR %	-47.83	-4.47	171.27	23.41	6.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	-47.83	-4.47	171.27	23.41	6.11
Dividend Per Share, 2 Yr. CAGR %	1.51	54.47	39.09	-8.33	8.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.36	16.17	25.14	9.37	6.66
Gross Profit, 3 Yr. CAGR %	5.95	20.11	29.63	13.69	7.93
EBITDA, 3 Yr. CAGR %	5.46	23.81	35.33	12.77	6.09
EBITA, 3 Yr. CAGR %	4.43	24.46	37.54	12.46	5.17
EBIT, 3 Yr. CAGR %	4.48	24.5	37.56	12.47	5.18
Earnings From Cont. Operations, 3 Yr. CAGR %	5.93	20.75	36.55	14.42	7.58
Net Income, 3 Yr. CAGR %	5.93	20.75	36.55	14.42	7.58
Normalized Net Income, 3 Yr. CAGR %	4.69	23.22	36.66	12.87	5.56
Diluted EPS Before Extra, 3 Yr. CAGR %	7.76	22.84	37.28	14.69	8.18
Accounts Receivable, 3 Yr. CAGR %	6.3	43.47	45.77	26.85	3.82
Inventory, 3 Yr. CAGR %	6.48	10.18	18.49	22.47	16.49
Net Property, Plant and Equip., 3 Yr. CAGR %	16.07	14.13	13.85	19.65	25.57
Total Assets, 3 Yr. CAGR %	5.65	14.63	21.83	19.89	11.5
Tangible Book Value, 3 Yr. CAGR %	10.06	14.64	24.26	19.7	11.16
Common Equity, 3 Yr. CAGR %	9.92	14.9	24.46	19.77	11.26
Cash From Operations, 3 Yr. CAGR %	-7.87	14.34	18.97	43.9	27.12
Capital Expenditures, 3 Yr. CAGR %	8.82	6.48	10.66	29.55	41.29
Levered Free Cash Flow, 3 Yr. CAGR %	-29.23	2.82	18.91	82.55	27.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	-29.23	2.82	18.91	82.55	27.53
Dividend Per Share, 3 Yr. CAGR %	7.77	22.78	36.97	14.72	8.18
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.08	20.17	14.33	7.45	16.62
Gross Profit, 5 Yr. CAGR %	16.15	23.12	15.69	9.55	20.46
EBITDA, 5 Yr. CAGR %	20.96	29.57	16.92	8.7	23.29
EBITA, 5 Yr. CAGR %	22.2	30.84	17	7.98	24.04
EBIT, 5 Yr. CAGR %	22.39	30.94	17.05	8	24.06
Earnings From Cont. Operations, 5 Yr. CAGR %	25.53	30.55	18.2	7.95	24.05
Net Income, 5 Yr. CAGR %	25.55	30.56	18.2	7.95	24.05
Normalized Net Income, 5 Yr. CAGR %	21.97	30.75	17.37	7.56	23.64
Diluted EPS Before Extra, 5 Yr. CAGR %	27.56	31.88	19.4	9.23	24.89
Accounts Receivable, 5 Yr. CAGR %	10.47	26.52	23.84	21.63	26.47
Inventory, 5 Yr. CAGR %	16.32	14.93	13.64	16.59	13.83
Net Property, Plant and Equip., 5 Yr. CAGR %	15.38	17.3	15.52	17.59	20.26
Total Assets, 5 Yr. CAGR %	12.43	14.62	13.85	14.33	15.48
Tangible Book Value, 5 Yr. CAGR %	13.02	16.01	15.76	14.47	17.31
Common Equity, 5 Yr. CAGR %	12.68	15.84	15.7	14.66	17.46
Cash From Operations, 5 Yr. CAGR %	16.02	15.66	17.97	18.06	18.13
Capital Expenditures, 5 Yr. CAGR %	36.65	26.18	9.89	20.26	26.25
Levered Free Cash Flow, 5 Yr. CAGR %	-3.76	9.23	21.13	10.61	13.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	-3.76	9.23	21.13	10.61	13.62
Dividend Per Share, 5 Yr. CAGR %	26.93	31.86	19.35	9.24	24.74